Samsung Biologics has newly appeared among the top searched stocks.


As of 10:31 AM on the 25th, Samsung Biologics is trading at 683,000 KRW, up 1.49% from the previous day. This is a 14.52% decrease compared to August 28. Samsung Biologics is known as the holding company for Samsung Group's bio business.

Today, foreigners are tentatively recorded as net buyers of 2,541 shares. Over the past five days, individual investors have net bought 137,942 shares, while foreigners and institutions have net sold 38,601 shares and 90,161 shares, respectively.


On September 22, Samsung Biologics was a market topic for its "strong performance due to a 385 billion KRW long-term CMO supply contract."





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing